-+ 0.00%
-+ 0.00%
-+ 0.00%
Co-Diagnostics Sets 1-for-25 Reverse Stock Split for Nov. 24
Share
Listen to the news
Co-Diagnostics Sets 1-for-25 Reverse Stock Split for Nov. 24
  • Co-Diagnostics will implement a 1-for-25 reverse stock split effective at 12:01 a.m. ET on November 24, 2026.
  • Split-adjusted trading begins November 24 on the Nasdaq Capital Market under CODX.
  • The split aims to maintain compliance with Nasdaq's $1 minimum bid price requirement while preserving capacity for equity financing.
  • Outstanding common shares are expected to fall to approximately 521,779 from 13,044,465; authorized shares will remain unchanged.
  • Fractional shares will be rounded up to the next whole share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611191700PR_NEWS_USPR_____LA03079) on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending